FindTrial
Sign In

Effect of oral vitamin D to pregnant mothers on vitamin D levels of their children at 6 months of age

Effect of oral vitamin D supplementation to pregnant mothers on vitamin D status of their exclusively breastfed infants at 6 months of age- A randomised triple blind placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010850
Enrollment
100
Registered
2017-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vitamin D3 capsules and Placebo: Strength of each capsule-60000 IU vitamin D3 or placebo Intervention2: NIL: NIL Intervention3: NIL: NIL Intervention4: capsule vitamin D3 (cholecalcifer

Sponsors

University College Of Medical Sciences l
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gestational age of 30-32 weeks,no current use of ATD and anticonvulsants,Hb >7gm/DL,BP 145cm,prepregnancy wt >47kg,residing within 10 kms of GTBH Infants: Term,AGA,APGAR >7 at 1 min,no apparent major congenital and chromosomal anomalies

Exclusion criteria

Exclusion criteria: Mother: Signs & symptoms of amnionitis Infants: Non vigorous infants with MSAF,LBW,Neonates having seizures,infants requiring blood transfusion

Design outcomes

Primary

MeasureTime frame
Primary outcome: proportion of infants having vitamin D3 levels 11ng/ml at 6 months of age in both the groups.Timepoint: 6 months of age of infants—

Secondary

MeasureTime frame
proportion of infants developing radiological and biochemical ricketsTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Prashant Prabhakar

Ucms & gtb hospital

drmmafaridi@gmail.com8800719116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026